Silver Spur Therapeutics
PrivateLast Round
Accelerator
Jun 17, 2025
Total Funding Raised
$220,000
Company Overview
Silver Spur Therapeutics operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was an Accelerator round in June 2025.
Silver Spur Therapeutics is a biotechnology company that develops a proprietary nanomedicine delivery platform using peptide amphiphile micelles to target kidney and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Silver Spur Therapeutics Comparables
Compare Silver Spur Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zeal Therapeutics, Inc. | 86% | |
| Nephrogen | 81% | |
| Judo Bio | 77% |
For institutional investors. Book with your work email.
Silver Spur Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 17, 2025 | ||||
| Accelerator | Mar 10, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Silver Spur Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| StoryHouse Ventures | Accelerator |
| University of Southern California | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2025
$220K round led by Techstars
For institutional investors. Book with your work email.
Silver Spur Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Silver Spur Therapeutics's valuation, stock price, and market status.
Is Silver Spur Therapeutics a public or private company?
Silver Spur Therapeutics is a private company.
What is the current stock price of Silver Spur Therapeutics?
Silver Spur Therapeutics is a private company, so its shares have no public market price. Caplight tracks Silver Spur Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Silver Spur Therapeutics worth (valuation)?
Valuation information for Silver Spur Therapeutics is not publicly available.
Can I buy Silver Spur Therapeutics stock?
Silver Spur Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Silver Spur Therapeutics's last funding round?
Silver Spur Therapeutics's most recent funding round was Accelerator on June 17, 2025.
Who are the main investors in Silver Spur Therapeutics?
Key investors in Silver Spur Therapeutics include Techstars.
Will Silver Spur Therapeutics IPO soon?
No public IPO plans have been announced for Silver Spur Therapeutics.
How can I track Silver Spur Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Silver Spur Therapeutics's shares on secondary markets.